Dr Wayne J. Hawthorne
Is Professor of Transplantation at the Department of Surgery, Westmead Clinical School, University of Sydney, Director of the National Pancreas and Islet Transplant Laboratories, Westmead Hospital, and also the Director of the Xenotransplantation Research Program at the Westmead Institute of Medical Research, Westmead, Sydney, Australia.
He is President Elect of the IXA and has been an IXA member for more than 20 years having served on the IXA council for the past four years. He is also Deputy Chair of the IXA Vanguard Committee, which fosters the development of younger IXA members. Over the years he has contributed to a number of significant initiatives for the IXA, most recently as Chair of the WHO-sponsored meeting to revisit the world guidelines for clinical xenotransplantation, resulting in the WHO “2018 Changsha Communiqué” (published in Xenotransplantation in April). An organizer of the 2017 IXA - FDA regulatory meeting at the 14th IXA Congress in Baltimore; the 2016 IXA - FDA regulatory consultation at the ATC in Boston; the 2015 IPITA/IXA/CTS Joint Congress Symposium; Prospects for Clinical Islet Xenotransplantation (CIX) in Melbourne and the 2nd International Conference on Clinical Islet Xenotransplantation, San Francisco, 2014.
He has also served on the Scientific Program Committees for the forthcoming IXA Congress in Munich, the 2019 IPITA Congress in Lyon (as IXA representative), the 2017 IXA Congress in Baltimore, and the 2015 IPITA/IXA/CTS Joint Congress in Melbourne. At a national level he has served for 5 years as a Council Member for the Transplantation Society of Australia and New Zealand (TSANZ) Scientific Program and Education Committee and as Xenotransplantation subcommittee Co-Chair.
His team were the first in Australia to perform Clinical allo and auto islet cell isolation and transplantation where they have completed almost 300 islet cell isolations for treatment of patients suffering from Type 1 diabetes. He was also the first in Australia to establish a Xeno Islet and Kidney Transplant programs in non-human primate models. He has ~200 journal publications, 12 book chapters and 600 published proceedings. My awards include: 2010 - XENOME Award for Transplantation from the European Union; 2007 - Key Opinion Leader in Transplantation (TTS) and 2003 the inaugural winner of the McKenzie Award for Outstanding Contribution to Transplantation (TSANZ).
08:30 - 10:00
|Session — Regulatory, FDA/EMA - Part 1||The 2018 Changsha Communiqué||Room A.021|
12:30 - 13:30
|Lunch & Learn — Career Development Session "Ask your burning questions"||-||Room A.021|
08:35 - 10:05
|Session — Replacement of Beta-Cell Function||Free islet xenotransplantation (immature)||Audimax Auditorium (A.030)|
13:40 - 15:10
|Session — Xenogeneic Cell Transplantation||Chairs||Audimax Auditorium (A.030)|
|Scientific Program Committee||Member|